As of 2025-09-16, the EV/EBITDA ratio of Twist Bioscience Corp (TWST) is -18.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Twist's latest enterprise value is 1,351.09 mil USD. Twist's TTM EBITDA according to its financial statements is -71.47 mil USD. Dividing these 2 quantities gives us the above Twist EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 15.8x | 14.6x |
| Forward P/E multiples | 15.8x - 18.8x | 17.3x |
| Fair Price | (15.37) - (15.35) | (15.52) |
| Upside | -159.8% - -159.7% | -160.3% |
| Date | EV/EBITDA |
| 2025-09-12 | -18.56 |
| 2025-09-11 | -18.81 |
| 2025-09-10 | -17.59 |
| 2025-09-09 | -18.37 |
| 2025-09-08 | -19.35 |
| 2025-09-05 | -18.94 |
| 2025-09-04 | -18.83 |
| 2025-09-03 | -19.14 |
| 2025-09-02 | -19.34 |
| 2025-08-29 | -19.96 |
| 2025-08-28 | -19.64 |
| 2025-08-27 | -20.15 |
| 2025-08-26 | -20.59 |
| 2025-08-25 | -20.31 |
| 2025-08-22 | -21.33 |
| 2025-08-21 | -19.54 |
| 2025-08-20 | -19.52 |
| 2025-08-19 | -20.48 |
| 2025-08-18 | -20.85 |
| 2025-08-15 | -20.93 |
| 2025-08-14 | -21.54 |
| 2025-08-13 | -21.38 |
| 2025-08-12 | -20.37 |
| 2025-08-11 | -20.52 |
| 2025-08-08 | -18.84 |
| 2025-08-07 | -18.30 |
| 2025-08-06 | -19.06 |
| 2025-08-05 | -20.42 |
| 2025-08-04 | -22.70 |
| 2025-08-01 | -25.63 |
| 2025-07-31 | -25.53 |
| 2025-07-30 | -26.51 |
| 2025-07-29 | -26.48 |
| 2025-07-28 | -28.03 |
| 2025-07-25 | -27.58 |
| 2025-07-24 | -26.81 |
| 2025-07-23 | -27.61 |
| 2025-07-22 | -27.44 |
| 2025-07-21 | -26.55 |
| 2025-07-18 | -26.89 |
| 2025-07-17 | -27.46 |
| 2025-07-16 | -28.17 |
| 2025-07-15 | -27.90 |
| 2025-07-14 | -29.11 |
| 2025-07-11 | -29.30 |
| 2025-07-10 | -29.67 |
| 2025-07-09 | -30.22 |
| 2025-07-08 | -28.41 |
| 2025-07-07 | -27.24 |
| 2025-07-03 | -29.42 |